PI3K acts in synergy with loss of PKC to elicit apoptosis via the UPR

Journal of Cellular Biochemistry

Volumn 107, Issue 1, 2009, Pages 76-85

  Guo, Jinjin ^a   Zhu, Tongbo ^a   Luo, Ling Yu ^a   Huang, Yi ^a   Sunkavalli, Raja G ^a   Chang, Yan Chen ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; ER; JNK; PI3K Akt; Ras; ROS; UPR

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE RAS; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN FOLDING; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CELL LINE; DNA FRAGMENTATION; FLOW CYTOMETRY; GENES, RAS; HUMANS; IMMUNOBLOTTING; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN KINASE C; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

MAMMALIA; RATTUS;

EID: 66149172264     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22102     Document Type: Article

References (37)

1. Adler V, Yin Z, Tew KD, Ronai Z. 1999. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18:6084-6086.
2. Aridor M, Balch WE. 1999. Integration of endoplasmic reticulum signaling in health and disease. Nat Med 5:745-751.
3. Barbacid M. 1987. Ras genes. Annu Rev Biochem 56:779-827.
4. Barsyte-Lovejoy D, Mao DY, Penn LZ. 2004. c-Myc represses the proximal promoters of GADD45a and GADD153 by a post-RNA polymerase II recruitment mechanism. Oncogene 23:3481-3486.
5. Benanti JA, Galloway DA. 2004. The normal response to Ras: Senescence or transformation? Mol Cell Biol 24:2842-2852.
6. Boguski MS, McCormick F. 1993. Proteins regulating Ras and its relatives. Nature 366:643-645.
7. Bos JL. 1989. Ras oncogenes in human cancer: A review. Cancer Res 49:4682-4689.
8. Chen CY, Faller DV. 1995. Direction of Ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene 20:1487-1498.
9. Chen CY, Juo P, Liou J, Yu Q, Blenis J, Faller DV. 2001. The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis. Cell Growth Differ 12:297-306.
10. Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR. 2006. Anti-oncotenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol 8:1053-1063.
11. Derijard B, Hibi M, Wu I-H, Barrett T, Su B, Deng T. 1994. JNK1: A protein kinase stimulated by UV light and Ha-ras that binds an phosphorylates the c-Jun activation domain. Cell 76:1025-1037.
12. Frey RS, Gao X, Javaid K, Siddiqui SS, Rahman A, Malik AB. 2006. Phosphatidylinositol 3-kinase gama signaling through protein kinase C theta induces NADPH oxidase-mediated oxidant generation and NF-kB activation in endothelial cells. J Biol Chem 281:16128-16138.
13. Fukadawa K, Rulong S, Resau J, Pinto S, Woude GF. 1995. Overexpression of mos oncogene product in Swiss 3T3 cells induces apoptosis preferentially during S-phase. Oncogene 10:1-8.
14. Hingorani SR, Tuveson DA. 2003. Ras redox: Rethinking how and where Ras acts. Curr Opin Genet Dev 13:6-13.
15. Irani K, Goldschmidt-Clemont PJ. 1998. Ras, superoxide and signal transduction. Biochem Pharmacol 55:1339-1346.
16. Joneson T, White MA, Wigler MH, Bar-Sagi D. 1996. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of Ras. Science 271:810-812.
17. Kang J-S, Krauss RS. 1996. Ras induces anchorage-independent growth by subverting multiple adhesion-regulated cell cycle events. Mol Cell Biol 16:3370-3380.
18. Kaufman RJ. 2002. Orchestrating the unfolded protein response in health and disease. J Clin Invest 110:1389-1398.
19. Khwaja A, Tatton L. 1999. Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J Biol Chem 274:36817-36823.
20. Koo HM, Gray-Goodrich M, Kohlhagen G, McWilliams MJ, Jeffers M, Vaigro-Wolff A. 1999. The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis. J Natl Cancer 91:236-244.
21. Li J, Lee B, Lee AS. 2006. Endoplasmic reticulum stress-induced apoptosis: Multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and MOXA by p53. J Biol Chem 281:7260-7270.
22. Liou JS, Chen CY, Chen JS, Faller DV. 2000. Oncogenic Ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species. J Biol Chem 275:39001-39011.
23. Ma P, Magut M, Chen X, Chen CY. 2002. p53 is necessary for the apoptotic response mediated by a transient increase of Ras activity. Mol Cell Biol 22:2928-2938.
24. Majumder PJ, Sellers WR. 2005. Akt-regulated pathways in prostate cancer. Oncogene 24:7465-7474.
25. Marshall CJ. 1996. Ras effectors. Curr Opin Cell Biol 8:197-204.
26. McCullough KD, Martindale JL, Klotz L-O, Aw T-Y, Holbrook NJ. 2001. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl-2 and perturbing the cellular redox state. Mol Cell Biol 21:1249-1259.
27. Mills EM, Takeda K, Yu ZX, Ferrans V, Katagiri Y, Jiang H. 1998. Nerve growth factor treatment prevents the increase in superoxide produce by epidermal growth factor in PC12 cells. J Biol Chem 273:22165-22168.
28. Mostefai HA, Agouni A, Carusio N, Mastronardi ML, Heymes C, Henrion D. 2008. Phosphatidylinositol-3-kinase and xanthine oxidase regulate nitric oxide and reactive oxygen species productions by apoptotic lymphocyte microparticles in endothelial cells. J Immunol 180:5028-5035.
29. Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457-467.
30. Ron D. 2006. Cell biology. Stressed cells cope with protein overload. Science 313:52-53.
31. Ron D, Habener JF. 1992. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Gene Dev 6:439-453.
32. Schroder M, Kaufman RJ. 2005. The mammalian unfolded protein response. Annu Rev Biochem 74:739-789.
33. Schwieger A, Bauer L, Hanusch J, Sers C, Schafer R, Bauer G. 2001. Ras oncogene expression determines sensitivity for intercellular induction of apoptosis. Carcinogenesis 22:1385-1392.
34. Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S, Sun P. 2002. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol 22:3389-3403.
35. Woodgett JR, Avruch J, Kyriakis J. 1996. The stress activated protein kinase pathway. Cancer Surv 27:127-138.
36. Ras. J Biol Chem 282:13199-13210.
37. Zhang K, Kaufman RJ. 2003. Unfolding the toxicity of cholesterol. Nat Cell Biol 5:769-770.